Sivik Global Healthcare LLC / NVO
Sivik Global Healthcare LLC’s Novo-Nordisk A S Position
Does Sivik Global Healthcare LLC own Novo-Nordisk A S (NVO)? Not currently — the last reported position was 75.0K shares worth $4M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q4 2025
Shares
75.0K
% of Portfolio
+1.11%
Quarters Held
18
position exited
Position History NVO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 75.0K | $4M | +1.11% |
| Q2 2025 | 100.0K | $7M | +1.88% |
| Q1 2025 | 70.0K | $5M | +2.63% |
| Q4 2024 | 70.0K | $6M | +3.17% |
| Q3 2024 | 90.0K | $11M | +4.54% |
| Q2 2024 | 90.0K | $13M | +4.61% |
| Q1 2024 | 92.5K | $12M | +2.78% |
| Q4 2023 | 90.0K | $9M | +3.89% |
| Q3 2023 | 90.0K | $8M | +4.14% |
| Q2 2023 | 50.0K | $8M | +1.89% |
| Q1 2023 | 60.0K | $10M | +4.10% |
| Q4 2022 | 50.0K | $7M | +3.18% |
| Q3 2022 | 40.0K | $4M | +2.21% |
| Q2 2022 | 60.0K | $7M | +3.80% |
| Q1 2022 | 45.0K | $5M | +2.06% |
| Q2 2020 | 210.0K | $7M | +2.44% |
| Q1 2020 | 250.0K | $8M | +3.22% |
| Q1 2019 | 135.0K | $7M | +2.60% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of NVO.